Developer docs
API playgroundTry for free, no card

Search company profiles

HUS Helsinki University Hospital

Full company profile

uuid002nvdl

Namestring
HUS Helsinki University Hospital
Legal namestring
HUS (Helsingin yliopistollinen sairaala)
Websiteurl
hus.fi
Company typeenum
Private
Founded yearint
1958
Descriptiontext

HUS Helsinki University Hospital is a public university hospital and municipal consortium (kuntayhtymä) operating under Finnish public healthcare law, and is the largest hospital district in Finland. Founded in 1958 and headquartered in the Uusimaa region with 10,000+ employees, HUS delivers specialised and tertiary medical care, emergency services, and acute treatment across an extensive multi-site network that includes Meilahti tower and triangle hospitals, Jorvi, Peijas, Hyvinkää, Lohja, Porvoo, Raasepori, Espoo, the Women's Hospital (Naistenklinikka), the New Children's Hospital, the Cancer Center, the Psychiatric Center, and numerous specialty clinics. The organisation is affiliated with the University of Helsinki's medical faculty, integrating clinical care with research and medical education, and operates documented research divisions including the MeVac vaccine research centre and children's clinical studies unit.

HUS's product portfolio spans traditional specialised care, novel treatment modalities, and digital services. Notable capabilities include Europe's first in-hospital Boron Neutron Capture Therapy (BNCT) facility — built on a 10-year collaboration with Neutron Therapeutics using its nuBeam accelerator-based neutron irradiation system, treating locally recurrent head and neck cancer in one or two sessions — a wearable home dialysis monitoring solution co-developed with VTT Technical Research Centre of Finland, and an ultrasonic needle biopsy device co-developed with Aalto University that vibrates at up to 30,000 times per second and yields tissue samples 2–3 times larger than conventional techniques. AI-assisted diagnostics are deployed clinically, with documented evidence of a 25% increase in pulmonary embolism detection rates. Digital patient-facing services include the Maisa patient portal, Omapolku health management platform, and online laboratory booking. Quality operations are managed under an ISO 9001-certified HUS Quality System.

HUS operates as a publicly funded healthcare provider rather than a commercial enterprise. Revenue is sourced from Finnish municipalities and the national government through the wellbeing services counties system, supplemented by nationally regulated standardised patient fees. The go-to-market is institutional and referral-based: patients access services through referrals from primary healthcare providers and emergency pathways, with no commercial sales motion or individually negotiated pricing. The organisation has no disclosed venture capital, private equity, or parent company ownership, and governance rests with the municipal member organisations of the consortium. Notable research and clinical partners include Neutron Therapeutics, VTT Technical Research Centre of Finland, Aalto University, and the Research Council of Finland.

Short descriptiontext

HUS Helsinki University Hospital is Finland's largest public university hospital and municipal consortium, delivering specialised and tertiary healthcare across more than 20 hospital sites in the Uusimaa region, serving residents through publicly funded care.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersUusimaa, Finland
HQ citystring
Uusimaa
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialized hospital care, university hospital services, oncology and cancer treatment, emergency medical services, clinical research and education
Industry1 code
1Hospital Shared Services, GPOs & System Support Organizations
CodeHLAFAAAOPrimaryYes
NAICS code2 codes
  • General Medical and Surgical Hospitals6221
  • General Medical and Surgical Hospitals622110
SIC code2 codes
  • Services-Hospitals8060
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
University Hospital Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Public Healthcare Services
TypeSubscription Recurring
Description

As a publicly funded university hospital, HUS receives funding from Finnish municipalities and the government through the wellbeing services counties system. Additional revenue comes from patient fees for treatments and services.

hus.fi
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

HUS Helsinki University Hospital is a publicly funded university hospital that provides specialized medical care, around-the-clock emergency services, and advanced diagnostics for residents of the Helsinki and Uusimaa region. It also delivers clinical research and professional medical education in cooperation with the University of Helsinki, operating multiple hospital sites and supporting digital patient services such as the Maisa portal and the Omapolku care pathway application.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 25% increase in pulmonary embolism detection at Helsinki University Hospital
+2 more records
Product overview1 text field

HUS Helsinki University Hospital operates as Finland's largest healthcare provider offering specialized medical services through a multi-site hospital network. The organization provides acute care, cancer treatment including Europe's first in-hospital Boron Neutron Capture Therapy, diagnostic services, research, and education. Digital services include Maisa patient portal, laboratory booking, and Omapolku health management platform. Research divisions include vaccine research (MeVac), children's clinical studies, and various specialized medical research centers. The hospital network spans multiple facilities including Meilahden sairaala, Jorvin sairaala, and specialized centers for cancer, cardiac, and neurological care.

Product and service6 records
1Specialized hospital care
CategorySpecialty healthcare services
Description

Tertiary and quaternary medical care delivered across multiple HUS hospital sites for patients referred from primary care, occupational healthcare, and other Finnish hospital districts.

2Emergency and on-call medical services
CategoryEmergency healthcare services
Description

24/7 emergency department and trauma care at HUS hospital sites for acute cases arriving directly or by ambulance.

3Oncology and cancer treatment services including BNCT
CategoryOncology services
Description

Multi-disciplinary cancer diagnostics and treatment, including boron neutron capture therapy (BNCT) and advanced radiotherapy delivered at HUS cancer centers.

4Diagnostic and laboratory services
CategoryDiagnostic services
Description

Specialty medical imaging, pathology, and laboratory diagnostics, including AI-assisted image analysis, supporting both HUS clinicians and external referrers.

5Digital patient services (Maisa portal and Omapolku)
CategoryDigital health services
Description

Online patient portal (Maisa) and care-pathway application (Omapolku) that allow patients to book appointments, view results, message care teams, and follow treatment plans.

6Clinical research and medical education
CategoryResearch and education services
Description

Biomedical and clinical research programs combined with undergraduate and postgraduate medical training delivered in partnership with the University of Helsinki.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-07
Description

Collaborative development of ultrasonic needle technology for tumour diagnostics. The device yields tissue samples 2-3 times larger than current needle biopsy techniques, vibrating up to 30,000 times per second. Successfully sampled lymph nodes in ten patients for potential improvement in diagnosing salivary gland, thyroid, and breast cancers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-12
Description

10-year collaboration culminating in Europe's first in-hospital Boron Neutron Capture Therapy facility at HUS. The facility uses Neutron Therapeutics' nuBeam accelerator-based neutron irradiation system. First patients treated since May 2025, with nine of ten planned patients in a clinical trial for locally recurrent head and neck cancer already treated.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-01-08
Description

Joint field test of wearable sensors for home dialysis monitoring, enrolling 36 volunteer patients over a six-month period. The sensors collect data on cardiac activity, hemodynamic and oxygen levels to assess treatment effectiveness between hospital visits. Funded by the Research Council of Finland.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Denmark's largest hospital and a Nordic leader in specialized care and clinical research, directly comparable to HUS in scope, scale, and academic medical center role.

TypeDirect peer
Description

Finland's second-largest university hospital, also operating under the Finnish municipal consortium model with overlapping clinical and research functions with HUS.

TypeDirect peer
Description

Sweden's premier university hospital, comparable to HUS in size, research intensity, and Nordic public hospital model with a similar mix of tertiary care, academic research, and innovation partnerships.

TypeDirect peer
Description

Norway's largest university hospital with comparable public funding model, research intensity, and multi-site structure to HUS.

TypeDirect peer
Description

Denmark's second-largest university hospital, comparable to HUS as a Nordic public academic medical center with strong research output.

TypeDirect peer
Description

Gothenburg-based Swedish university hospital with similar public governance, multi-site operations, and research-driven care delivery comparable to HUS.

TypeDirect peer
Description

Norway's third-largest university hospital, operating under a similar public Nordic model with comparable tertiary care and research functions to HUS.

8Helsinki University Hospital (HUS) itself is the anchor; see listed Nordic university hospitals as peers
TypeDirect peer
Description

HUS is the largest university hospital in Finland, providing tertiary care across the Helsinki region with strong research ties.

TypeDirect peer
Description

Swedish university hospital with similar public governance and academic medical center role, providing tertiary and specialized care comparable to HUS.

TypeDirect peer
Description

Another major Finnish university hospital providing tertiary care and research, with similar regulatory, funding, and operational structure to HUS.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HUS Helsinki University Hospital

University Hospital Serviceshus.fi

HUS Helsinki University Hospital is Finland's largest public university hospital and municipal consortium, delivering specialised and tertiary healthcare across more than 20 hospital sites in the Uusimaa region, serving residents through publicly funded care.

What HUS Helsinki University Hospital does

HUS Helsinki University Hospital is a public university hospital and municipal consortium (kuntayhtymä) operating under Finnish public healthcare law, and is the largest hospital district in Finland. Founded in 1958 and headquartered in the Uusimaa region with 10,000+ employees, HUS delivers specialised and tertiary medical care, emergency services, and acute treatment across an extensive multi-site network that includes Meilahti tower and triangle hospitals, Jorvi, Peijas, Hyvinkää, Lohja, Porvoo, Raasepori, Espoo, the Women's Hospital (Naistenklinikka), the New Children's Hospital, the Cancer Center, the Psychiatric Center, and numerous specialty clinics. The organisation is affiliated with the University of Helsinki's medical faculty, integrating clinical care with research and medical education, and operates documented research divisions including the MeVac vaccine research centre and children's clinical studies unit.

HUS's product portfolio spans traditional specialised care, novel treatment modalities, and digital services. Notable capabilities include Europe's first in-hospital Boron Neutron Capture Therapy (BNCT) facility — built on a 10-year collaboration with Neutron Therapeutics using its nuBeam accelerator-based neutron irradiation system, treating locally recurrent head and neck cancer in one or two sessions — a wearable home dialysis monitoring solution co-developed with VTT Technical Research Centre of Finland, and an ultrasonic needle biopsy device co-developed with Aalto University that vibrates at up to 30,000 times per second and yields tissue samples 2–3 times larger than conventional techniques. AI-assisted diagnostics are deployed clinically, with documented evidence of a 25% increase in pulmonary embolism detection rates. Digital patient-facing services include the Maisa patient portal, Omapolku health management platform, and online laboratory booking. Quality operations are managed under an ISO 9001-certified HUS Quality System.

HUS operates as a publicly funded healthcare provider rather than a commercial enterprise. Revenue is sourced from Finnish municipalities and the national government through the wellbeing services counties system, supplemented by nationally regulated standardised patient fees. The go-to-market is institutional and referral-based: patients access services through referrals from primary healthcare providers and emergency pathways, with no commercial sales motion or individually negotiated pricing. The organisation has no disclosed venture capital, private equity, or parent company ownership, and governance rests with the municipal member organisations of the consortium. Notable research and clinical partners include Neutron Therapeutics, VTT Technical Research Centre of Finland, Aalto University, and the Research Council of Finland.

HUS Helsinki University Hospital firmographics

Firmographics
Name
HUS Helsinki University Hospital
Legal name
HUS (Helsingin yliopistollinen sairaala)
Website
https://hus.fi
Company type
Private
Founded year
1958
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
HUS Helsinki University Hospital is Finland's largest public university hospital and municipal consortium, delivering specialised and tertiary healthcare across more than 20 hospital sites in the Uusimaa region, serving residents through publicly funded care.
Ownership category
akta.pro rank

HUS Helsinki University Hospital industry classification

Industry
Product category
University Hospital Services
NAICS
General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110)
SIC
Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Hospital Shared Services, GPOs & System Support Organizations (HLAFAAAO)

Keywords

  • Specialized hospital care
  • University hospital services
  • Oncology and cancer treatment
  • Emergency medical services
  • Clinical research and education

Where HUS Helsinki University Hospital is headquartered

Location

Headquarters

HQ city
Uusimaa
HQ country
Finland
HQ region
Europe

Offices5 records

Markets served

HUS Helsinki University Hospital business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

  1. Public Healthcare Services: As a publicly funded university hospital, HUS receives funding from Finnish municipalities and the government through the wellbeing services counties system. Additional revenue comes from patient fees for treatments and services.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

HUS Helsinki University Hospital product offering

Product offering

Core offering

HUS Helsinki University Hospital is a publicly funded university hospital that provides specialized medical care, around-the-clock emergency services, and advanced diagnostics for residents of the Helsinki and Uusimaa region. It also delivers clinical research and professional medical education in cooperation with the University of Helsinki, operating multiple hospital sites and supporting digital patient services such as the Maisa portal and the Omapolku care pathway application.

Product overview

HUS Helsinki University Hospital operates as Finland's largest healthcare provider offering specialized medical services through a multi-site hospital network. The organization provides acute care, cancer treatment including Europe's first in-hospital Boron Neutron Capture Therapy, diagnostic services, research, and education. Digital services include Maisa patient portal, laboratory booking, and Omapolku health management platform. Research divisions include vaccine research (MeVac), children's clinical studies, and various specialized medical research centers. The hospital network spans multiple facilities including Meilahden sairaala, Jorvin sairaala, and specialized centers for cancer, cardiac, and neurological care.

Differentiator

Problem solved

Functional benefit

Products and services

  • Specialized hospital care Tertiary and quaternary medical care delivered across multiple HUS hospital sites for patients referred from primary care, occupational healthcare, and other Finnish hospital districts.
  • Emergency and on-call medical services 24/7 emergency department and trauma care at HUS hospital sites for acute cases arriving directly or by ambulance.
  • Oncology and cancer treatment services including BNCT Multi-disciplinary cancer diagnostics and treatment, including boron neutron capture therapy (BNCT) and advanced radiotherapy delivered at HUS cancer centers.
  • Diagnostic and laboratory services Specialty medical imaging, pathology, and laboratory diagnostics, including AI-assisted image analysis, supporting both HUS clinicians and external referrers.
  • Digital patient services (Maisa portal and Omapolku) Online patient portal (Maisa) and care-pathway application (Omapolku) that allow patients to book appointments, view results, message care teams, and follow treatment plans.
  • Clinical research and medical education Biomedical and clinical research programs combined with undergraduate and postgraduate medical training delivered in partnership with the University of Helsinki.

Quantifiable outcome

  • 25% increase in pulmonary embolism detection at Helsinki University Hospital
  • +2 more outcomes

Companies that use HUS Helsinki University Hospital

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

HUS Helsinki University Hospital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature4 records

HUS Helsinki University Hospital partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Aalto UniversitycoreStrategic or Co-development Partner · 7 May 2026Collaborative development of ultrasonic needle technology for tumour diagnostics. The device yields tissue samples 2-3 times larger than current needle biopsy techniques, vibrating up to 30,000 times per second. Successfully sampled lymph nodes in ten patients for potential improvement in diagnosing salivary gland, thyroid, and breast cancers.
  • Neutron Therapeutics LLCcoreStrategic or Co-development Partner · 12 February 202610-year collaboration culminating in Europe's first in-hospital Boron Neutron Capture Therapy facility at HUS. The facility uses Neutron Therapeutics' nuBeam accelerator-based neutron irradiation system. First patients treated since May 2025, with nine of ten planned patients in a clinical trial for locally recurrent head and neck cancer already treated.
  • VTT Technical Research Centre of FinlandcoreTechnology or Integration · 8 January 2026Joint field test of wearable sensors for home dialysis monitoring, enrolling 36 volunteer patients over a six-month period. The sensors collect data on cardiac activity, hemodynamic and oxygen levels to assess treatment effectiveness between hospital visits. Funded by the Research Council of Finland.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

HUS Helsinki University Hospital competitors and assessment

Company assessment

Direct peers

  • Rigshospitalet (Copenhagen University Hospital): Denmark's largest hospital and a Nordic leader in specialized care and clinical research, directly comparable to HUS in scope, scale, and academic medical center role.
  • Tampere University Hospital (TAYS): Finland's second-largest university hospital, also operating under the Finnish municipal consortium model with overlapping clinical and research functions with HUS.
  • Karolinska University Hospital: Sweden's premier university hospital, comparable to HUS in size, research intensity, and Nordic public hospital model with a similar mix of tertiary care, academic research, and innovation partnerships.
  • Oslo University Hospital: Norway's largest university hospital with comparable public funding model, research intensity, and multi-site structure to HUS.
  • Aarhus University Hospital: Denmark's second-largest university hospital, comparable to HUS as a Nordic public academic medical center with strong research output.
  • Sahlgrenska University Hospital: Gothenburg-based Swedish university hospital with similar public governance, multi-site operations, and research-driven care delivery comparable to HUS.
  • St. Olavs Hospital (Trondheim University Hospital): Norway's third-largest university hospital, operating under a similar public Nordic model with comparable tertiary care and research functions to HUS.
  • Helsinki University Hospital (HUS) itself is the anchor; see listed Nordic university hospitals as peers: HUS is the largest university hospital in Finland, providing tertiary care across the Helsinki region with strong research ties.
  • Uppsala University Hospital: Swedish university hospital with similar public governance and academic medical center role, providing tertiary and specialized care comparable to HUS.
  • Turku University Hospital (TYKS): Another major Finnish university hospital providing tertiary care and research, with similar regulatory, funding, and operational structure to HUS.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

HUS Helsinki University Hospital social profiles

Digital presence

HUS Helsinki University Hospital compliance and trust

Trust signal

Compliance1 record

HUS Helsinki University Hospital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HUS Helsinki University Hospital leadership team

Management profile

Number of profiles

Profiles1 record

HUS Helsinki University Hospital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HUS Helsinki University Hospital M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HUS Helsinki University Hospital

What does HUS Helsinki University Hospital do?

HUS Helsinki University Hospital is a publicly funded university hospital that provides specialized medical care, around-the-clock emergency services, and advanced diagnostics for residents of the Helsinki and Uusimaa region. It also delivers clinical research and professional medical education in cooperation with the University of Helsinki, operating multiple hospital sites and supporting digital patient services such as the Maisa portal and the Omapolku care pathway application.

Is HUS Helsinki University Hospital a public or private company?

HUS Helsinki University Hospital is a private company. It is classified as state government owned and is currently operating.

When was HUS Helsinki University Hospital founded?

HUS Helsinki University Hospital was founded in 1958. It employs 5,001 to 10,000 people.

Where is HUS Helsinki University Hospital based?

HUS Helsinki University Hospital is headquartered in Uusimaa, Finland, in the Europe region.

How does HUS Helsinki University Hospital make money?

One revenue line is on record: public Healthcare Services.

Who are HUS Helsinki University Hospital's main competitors?

Direct peers on record are Rigshospitalet (Copenhagen University Hospital), Tampere University Hospital (TAYS), Karolinska University Hospital, Oslo University Hospital, Aarhus University Hospital, Sahlgrenska University Hospital, St. Olavs Hospital (Trondheim University Hospital), Helsinki University Hospital (HUS) itself is the anchor; see listed Nordic university hospitals as peers, Uppsala University Hospital and Turku University Hospital (TYKS).

Does HUS Helsinki University Hospital have an API?

No public API is recorded for HUS Helsinki University Hospital.

What industry is HUS Helsinki University Hospital in?

HUS Helsinki University Hospital's product category is University Hospital Services. Its primary akta.pro industry code is HLAFAAAO, Hospital Shared Services, GPOs & System Support Organizations. Its NAICS code is 6221 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Helsinki TimesYle: Senior psychiatrists resign from HUS amid restructuringSenior psychiatrists at Helsinki University Hospital have resigned amid planned restructuring of psychiatric services in eastern and central Uusimaa. Five senior doctors at Hyvinkää Hospital have left, with resignations taking effect in October. HUS plans to cover vacancies with internal transfers and recruitment, while the restructuring takes effect in 2027.News-MedicalStudy shows effectiveness of surgical treatment for chronic rhinosinusitis with nasal polypsA randomized controlled trial conducted by Helsinki University Hospital, Kuopio University Hospital, and the University of Eastern Finland compared full versus limited endoscopic sinus surgery in 97 patients with chronic rhinosinusitis with nasal polyps, finding that both surgical approaches significantly improved quality of life two years post-surgery. Full surgery demonstrated better outcomes for sense of smell recovery and reduced nasal polyp size compared to limited surgery, though the overall quality-of-life difference between groups was not statistically significant. The study, published in the journal Allergy, provides high-quality evidence supporting the effectiveness of surgical treatment for this condition.DevdiscourseAI in Healthcare Delivers Real Results, but WHO Says Better Policies Will Decide Its Global SuccessThe World Health Organization Regional Office for Europe released a report presenting evidence from 11 real-world AI implementations across Finland, Israel, Latvia, Norway, Portugal, Spain and the United Kingdom, demonstrating measurable improvements in clinical care and hospital operations including a 25% increase in pulmonary embolism detection at Helsinki University Hospital and up to 80% reductions in organ-contouring time at Norway's Haukeland University Hospital. The report argues that successful AI adoption depends on strong governance, reliable health data, skilled professionals and continuous monitoring rather than sophisticated algorithms alone, and calls for investment in digital infrastructure, workforce training and national governance systems. With the global health workforce expected to face an 11 million shortage by 2030, WHO recommends that countries adopt AI through a phased approach based on institutional capacity, emphasizing that responsible implementation rather than technology alone will determine whether AI delivers lasting improvements in health outcomes.NewswiseNew Ultrasonic Needle Yields Samples 2–3 Times Larger, Potentially Reshaping Cancer DiagnosticsResearchers at Aalto University in Finland have developed a new ultrasonic needle for tumour diagnostics that yields tissue samples two to three times larger than current needle biopsy techniques, with trials conducted in collaboration with Helsinki University Hospital. The device uses ultrasound amplified at the needle tip, vibrating up to 30,000 times per second to detach and collect tumour tissue with minimal invasiveness. The technology, which has successfully sampled lymph nodes in ten patients, could improve diagnosis of salivary gland, thyroid, and breast cancers while potentially avoiding unnecessary high-risk surgeries.PR NewswireNeutron Therapeutics and Helsinki University Hospital Hold Ribbon Cutting Ceremony for Europe's first In-Hospital Boron Neutron Capture Therapy FacilityNeutron Therapeutics LLC and Helsinki University Hospital held a ribbon-cutting ceremony for Europe\'s first in-hospital Boron Neutron Capture Therapy facility, culminating a 10-year collaboration with the first patients treated since May 2025. The facility uses Neutron Therapeutics\' nuBeam® accelerator-based neutron irradiation system, and nine of ten planned patients in a clinical trial for locally recurrent head and neck cancer have already been treated. BNCT is an approved cancer therapy in Japan and is under clinical research in China, Korea, Taiwan, and now Finland, offering targeted radiation treatment that can be completed in one or two sessions.Yle.fiNYE firework mishaps lead to several eye injuries across FinlandNew Year's Eve fireworks caused at least 11 eye injuries across Finland, with six patients treated at Helsinki University Hospital by noon on New Year's Day. The most severe case involved a child under 15 who suffered a serious eye burn requiring overnight surgery. National figures will be available later in January.Business Wire BlogMMI’s Symani® Robotic Surgical System Surpasses 500 Clinical ProceduresMedical Microinstruments, Inc. (MMI) announced that its Symani® Robotic Surgical System has completed over 500 in-human surgeries within the European Union. The milestone case, a lymphatic repair performed at HUS Helsinki University Hospital in Finland, highlights the system's adoption for complex soft tissue procedures such as free flap reconstructions and nerve repairs. This achievement underscores the technology's growing role in expanding access to microsurgical treatments for patients with complex conditions.PR NewswireCGI and Helsinki University Hospital develop AI solution for reviewing brain CT scans and detecting brain hemorrhagesCGI has partnered with Helsinki University Hospital and Planmeca to develop an AI solution called AI Head Analysis that assists radiologists in interpreting brain CT scans and detecting non-traumatic brain hemorrhages, with the solution recently approved for retrospective testing at Helsinki University Hospital. The collaboration, part of CGI's ESG strategy, has opened a testbed environment enabling hospitals worldwide to test the algorithm platform independently of any hospital's patient data or systems. Neurology journal has published research on the AI-based diagnostics, and independent validation has been conducted by hospitals including major university hospitals in Switzerland.GlobeNewswireNexstim Announces Results of the Pilot Study in Chronic Pain Treatment at Helsinki University HospitalNexstim announced completion of a pilot study at Helsinki University Hospital testing its NBT system for chronic neuropathic pain in five patients. No serious adverse events occurred, and no clinically meaningful pain relief was observed. The company will continue seeking new ways to help therapy-resistant patients.GlobeNewswireNEXSTIM PLC PROVIDES AN UPDATE ON THE PILOT STUDY IN CHRONIC PAIN TREATMENT AT HELSINKI UNIVERSITY HOSPITALNexstim reported that treatment of four of five patients in a chronic neuropathic pain pilot study at Helsinki University Hospital was completed by end of Q3 2021. The study tests an accelerated iTBS protocol, with results to be made public once available.